Connect with ABL at the Immunogenicity Summit Nov. 11-13 in DC
As leaders in immunological evaluations, ABL will attend the Immunogenicity Summit 2013 at the Hyatt Regency on Capitol Hill in Washington, D.C. on November 11-13. Come visit Booth #15.
ABL has decades of experience performing immunogenicity and PK evaluations. For preclinical and clinical studies, we utilize immunological, molecular, and cell-based assay platforms for candidate selection. We offer proof-of-concept in vivo studies with preclinical immunomonitoring and efficacy and potency testing. We have extensiive assay development capabilities to measure cellular and humoral immunity of your product in preclinical and clinical settings.
Email us at info@ablinc.com to schedule an appointment at the conference, visit our facility, or to get a proposal for your specific project.
